Michigan Chapter of AACE 2017 Annual Meeting & Symposium

September 22, 2017 to September 23, 2017

The Michigan Chapter of AACE program committee has worked very hard to provide a relevant activity for the practicing clinical physician and other healthcare providers seeking education with an emphasis in endocrine disease.

This program has been planned to provide pertinent scientific and clinical information to help you achieve the best solutions in the diagnosis and therapeutic management of patients presenting with endocrine disease. Attendees will obtain updates in not only common and uncommon endocrine disorders, but also newer treatment modalities.

Providing exceptional patient care requires continuing high quality education. The American Association of Clinical Endocrinologists (AACE) was founded in 1991 by a visionary group of leaders to serve as the active voice for clinical endocrinologists. The impetus behind AACE's efforts has always been quality and cost-effective patient care for those with endocrine diseases and disorders. We hope that you will find this program of great value to you in your practice.

Target Audience

Endocrinologists, MDs / Dos, advanced practice clinicians and other healthcare professionals interested in the treatment of endocrine disease living or working in Michigan.

Learning Objectives

  1. The participant will be able to select the appropriate tests to order for the initial evaluation for suspected hypogonadism
  2. The participant will understand the controversies about the free testosterone hypothesis
  3. The participant will understand how to weigh the risks and benefits of testosterone therapy for men with a history of cardiovascular disease, prostate disease or thromboembolic disease
  4. Review clinical presentation of diabetic gastroparesis
  5. Discuss the steps in gastroparesis diagnosis
  6. Review practical treatment approaches
  7. After participating in a pre-meeting assessment tool, attendees will be able to recognize areas of potential shortcoming and strive to improve knowledge and consequential healthcare practices.
  8. To understand the differential diagnosis of hypocalcemia and hypoparathyroidism
  9. Initiate treatment for hypoparathyroidism with calcium, vitamin D3 and calcitriol
  10. Understand clinical circumstances in which you might consider therapy with parathyroid hormone and thiazide diuretics
  11. The participant will understand the different mechanisms of action of anti-osteoporotic drugs
  12. The participant will recognize the major adverse effects of anti-osteoporotic drugs
  13. The participant will be able to formulate a treatment plan utilizing anti-osteoporotic drugs of different classes
  14. Identify patients with genetic disorder
  15. Interpret test results
  16. Surveillance of gene carriers
  17. Define subclinical Cushing’s and the epidemiology of the metabolic manifestations of subclinical Cushing’s.
  18. Understand the current evidence for operative and non-operative management
  19. Identify the gaps in knowledge with regards to subclinical Cushing’s
  20. Understand the role US patterns for thyroid nodule risk evaluation for FNA
  21. Recognize the currently available molecular tests for thyroid nodule diagnosis
  22. Recognize how sonographic patterns may alter cancer risk based upon cytologic diagnosis
  23. At the conclusion of the meeting, attendees will be able to measure learning that occurred that will enable the use of new healthcare techniques and practices and to review or confirm existing care modalities.
Additional information
Available for MOC Points?: 
No
Practice Area: 
Diabetes
Hypoglycemia
Obesity
General Endo
Course summary
Available credit: 
  • 6.00 AMA
  • 6.00 Attendance
Course opens: 
09/22/2017
Course expires: 
09/23/2018
Event starts: 
09/22/2017 - 5:30pm
Event ends: 
09/23/2017 - 2:15pm
Cost:
$0.00

Friday, September 22, 2017

5:30 - 6:15 PMRegistration
6:15 - 6:30 PMBuffet Dinner
6:30 - 6:45 PMWelcome
6:45 - 7:30 PMDiagnosis of Hypogonadism:
Should T be free?

Bradley Anawalt, MD
Objectives:
  1. The participant will be able to select the appropriate tests to order for the initial evaluation for suspected hypogonadism
  2. The participant will understand the controversies about the free testosterone hypothesis
  3. The participant will understand how to weigh the risks and benefits of testosterone therapy for men with a history of cardiovascular disease, prostate disease or thromboembolic disease
7:30 - 8:15 PMDiagnosis and Management of Diabetic Gastroparesis:
Challenges and clinical pearls

Rodica Busui, MD, PhD
Objectives:
  1. Review clinical presentation of diabetic gastroparesis
  2. Discuss the steps in gastroparesis diagnosis
  3. Review practical treatment approaches

Saturday, September 23, 2017

7:00 - 8:00 AMRegistration / Continental Breakfast
8:00 - 8:10 AMOpening Remarks and Pre-Meeting Assessment
Objectives:
  1. After participating in a pre-meeting assessment tool, attendees will be able to recognize areas of potential shortcoming and strive to improve knowledge and consequential healthcare practices.
8:10 - 9:00 AMAn Update on Hypoparathyroidism and Hypocalcemia:
New therapeutic options

Dolores Shoback, MD
Objectives:
  1. To understand the differential diagnosis of hypocalcemia and hypoparathyroidism
  2. Initiate treatment for hypoparathyroidism with calcium, vitamin D3 and calcitriol
  3. Understand clinical circumstances in which you might consider therapy with parathyroid hormone and thiazide diuretics
9:00 - 9:50 AMUpdate on Osteoporosis Treatment:
Beyond bisphosphonate therapy

Henry Bone, MD, FACE
Objectives:
  1. The participant will understand the different mechanisms of action of anti-osteoporotic drugs
  2. The participant will recognize the major adverse effects of anti-osteoporotic drugs
  3. The participant will be able to formulate a treatment plan utilizing anti-osteoporotic drugs of different classes
9:50 - 10:20 AMBreak
10:20 - 11:10 AMGenetics in Endocrine Oncology – A Practical Approach
Tobias Else, MD
Objectives:
  1. Identify patients with genetic disorder
  2. Interpret test results
  3. Surveillance of gene carriers
11:10 - 12:00 PMSubclinical Cushing’s: Is a chance to cut, a chance to cure?
Dhaval Patel, MD
Objectives:
  1. Define subclinical Cushing’s and the epidemiology of the metabolic manifestations of subclinical Cushing’s.
  2. Understand the current evidence for operative and non-operative management
  3. Identify the gaps in knowledge with regards to subclinical Cushing’s
12:00 - 1:15 PMLunch/Business Meeting
1:15 - 2:05 PMThyroid Nodule Update
Susan Mandel, MD, MPH, FACP, FACE
Objectives:
  1. Understand the role US patterns for thyroid nodule risk evaluation for FNA
  2. Recognize the currently available molecular tests for thyroid nodule diagnosis
  3. Recognize how sonographic patterns may alter cancer risk based upon cytologic diagnosis
2:05 - 2:15 PMPost Meeting Assessment
Susan Mandel, MD, MPH, FACP, FACE
Objectives:
  1. At the conclusion of the meeting, attendees will be able to measure learning that occurred that will enable the use of new healthcare techniques and practices and to review or confirm existing care modalities.
Southfield, MI
United States

Bradley D. Anawalt, MD, FACP
Chief of Medicine, University of Washington Medical Center
Professor and Vice Chair of Medicine, University of Washington
Seattle, WA

Henry G. Bone, MD, FACP, FACE
Director
Michigan Bone & Mineral Clinic, PC
Detroit, MI

Rodica Busui (Pop-Busui), MD, PhD
Professor of Internal Medicine, Metabolism, Endocrinology and Diabetes
Co-Director Neuropathy Center
Associate Chair for Clinical Research Department of Internal Medicine
University of Michigan
Ann Arbor, MI

Tobias Else, MD
Endocrine Oncology & Cancer Genetics Clinic
Dept. of Internal Medicine
Division of Metabolism, Endocrinology and Diabetes
University of Michigan
Ann Arbor, MI

Susan J. Mandel, MD, MPH, FACP, FACE
Professor of Medicine and Radiology
Associate Chief, Division of Endocrinology, Diabetes, and Metabolism
Perelman School of Medicine, University of Pennsylvania
Philadelphia PA

Dhaval Patel, MD
Assistant Professor of Surgery
National Institutes of Health, National Cancer Institute
Endocrine Oncology Branch
Bethesda, MD

Dolores Shoback, MD
Professor of Medicine
University of California
San Francisco, CA

* Indicates both a member of the Program Committee and faculty.

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the American Association of Clinical Endocrinologists (AACE) and the Michigan Chapter of AACE. The American Association of Clinical Endocrinologists (AACE) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The American Association of Clinical Endocrinologists (AACE) designates this live activity for a maximum of 6.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Available Credit

  • 6.00 AMA
  • 6.00 Attendance

Accreditation Period

Course opens: 
09/22/2017
Course expires: 
09/23/2018

Price

Cost:
$0.00
Please login or register to take this course.